Zobrazeno 1 - 10
of 493
pro vyhledávání: '"Joseph M Chan"'
Autor:
Law, Andrew M. (AUTHOR) andrew.law@newcastle.ac.uk
Publikováno v:
Europe-Asia Studies. Sep2023, Vol. 75 Issue 7, p1236-1238. 3p.
Autor:
Jean-Philippe Béja
Publikováno v:
China Information. 36:433-435
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d94f42fa4c4b7c707309ad718e3195ec
https://doi.org/10.1177/0920203x221130402b
https://doi.org/10.1177/0920203x221130402b
Autor:
Sebastian Veg
Publikováno v:
The China Quarterly. 251:969-971
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cec329714a43e33e93581d97f4c73034
https://doi.org/10.1017/s0305741022001059
https://doi.org/10.1017/s0305741022001059
Autor:
Rusciano, Frank Louis
Publikováno v:
The Public Opinion Quarterly, 2002 Dec 01. 66(4), 640-644.
Externí odkaz:
https://www.jstor.org/stable/3078715
Autor:
Alvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, Fathema Uddin, Swanand Rakhade, Vidushi Durani, Amin Sabet, Moniquetta Shafer, Wouter R. Karthaus, Samir Zaidi, Yingqian A. Zhan, Parvathy Manoj, Harsha Sridhar, Dennis Kinyua, Hong Zhong, Barbara P. Mello, Metamia Ciampricotti, Umesh K. Bhanot, Irina Linkov, Juan Qiu, Radhika A. Patel, Colm Morrissey, Sanjoy Mehta, Jesse Barnes, Michael C. Haffner, Nicholas D. Socci, Richard P. Koche, Elisa de Stanchina, Sonia Molina-Pinelo, Sohrab Salehi, Helena A. Yu, Joseph M. Chan, Charles M. Rudin
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-14 (2024)
Abstract Neuroendocrine (NE) transformation is a mechanism of resistance to targeted therapy in lung and prostate adenocarcinomas leading to poor prognosis. Up to date, even if patients at high risk of transformation can be identified by the occurren
Externí odkaz:
https://doaj.org/article/501fe4c8a5e9423ca573e0d9f455d0b2
Autor:
Gary Tang
Publikováno v:
The China Journal. 85:249-252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4710e64f3e66c340f26e0f3bd9273aea
https://doi.org/10.1086/709682
https://doi.org/10.1086/709682
Autor:
Edmund W. Cheng
Publikováno v:
The China Quarterly. 238:553-555
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0a61f15d928923e02adbf46eaa36d56
https://doi.org/10.1017/s0305741019000560
https://doi.org/10.1017/s0305741019000560
Autor:
Hirokazu Taniguchi, Shweta S. Chavan, Andrew Chow, Joseph M. Chan, Hiroshi Mukae, Charles M. Rudin, Triparna Sen
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionImmune checkpoint blockade (ICB) with or without chemotherapy has a very modest benefit in patients with small cell lung cancer (SCLC). SCLC tumors are characterized by high tumor mutation burden (TMB) and low PD-L1 expression. Therefore,
Externí odkaz:
https://doaj.org/article/868c6a6e68f04b8d9bd28b2cfda79613
Publikováno v:
Hong Kong Studies. 2(1):95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::41857d06eaa734c06180f077223a1198
https://hdl.handle.net/1874/409123
https://hdl.handle.net/1874/409123